US Stock MarketDetailed Quotes

ORKA Oruka Therapeutics

Watchlist
  • 20.750
  • +0.250+1.22%
Close Nov 22 16:00 ET
  • 20.650
  • -0.100-0.48%
Post 20:01 ET
726.22MMarket Cap-54605P/E (TTM)

Oruka Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
--410.88M
--15.12M
--27.74M
-Cash and cash equivalents
--410.88M
--15.12M
--27.74M
Receivables
--0
--0
--0
Prepaid assets
----
--1.43M
----
Other current assets
--2.07M
--275K
----
Total current assets
--412.95M
--16.82M
--27.74M
Non current assets
Net PPE
--1.1M
--999K
----
-Gross PPE
--1.1M
--999K
----
Other non current assets
--43K
--2.36M
--488K
Total non current assets
--1.14M
--3.36M
--488K
Total assets
--414.09M
--20.18M
--28.23M
Liabilities
Current liabilities
Payables
--8.5M
--18.02M
--5.9M
-accounts payable
--8.5M
--2.58M
--5.9M
-Due to related parties current
----
--15.44M
----
Current accrued expenses
--777K
--795K
--1.13M
Current debt and capital lease obligation
--146K
--61K
----
-Current capital lease obligation
--146K
--61K
----
Other current liabilities
--7.68M
--430K
--56K
Current liabilities
--18.04M
--19.36M
--7.17M
Non current liabilities
Long term debt and capital lease obligation
--842K
--25.91M
--24.98M
-Long term debt
----
--24.98M
--24.98M
-Long term capital lease obligation
--842K
--925K
----
Non current accrued expenses
----
--961K
--214K
Preferred securities outside stock equity
--52.84M
--2.93M
--2.93M
Total non current liabilities
--53.68M
--29.8M
--28.13M
Total liabilities
--71.72M
--49.16M
--35.29M
Shareholders'equity
Share capital
--2.97M
--0
--1K
-common stock
--35K
--0
--1K
-Preferred stock
--2.93M
----
----
Retained earnings
---57.94M
---29.32M
---7.08M
Paid-in capital
--397.35M
--339K
--17K
Total stockholders'equity
--342.37M
---28.98M
---7.06M
Total equity
--342.37M
---28.98M
---7.06M
Currency Unit
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments --410.88M--15.12M--27.74M
-Cash and cash equivalents --410.88M--15.12M--27.74M
Receivables --0--0--0
Prepaid assets ------1.43M----
Other current assets --2.07M--275K----
Total current assets --412.95M--16.82M--27.74M
Non current assets
Net PPE --1.1M--999K----
-Gross PPE --1.1M--999K----
Other non current assets --43K--2.36M--488K
Total non current assets --1.14M--3.36M--488K
Total assets --414.09M--20.18M--28.23M
Liabilities
Current liabilities
Payables --8.5M--18.02M--5.9M
-accounts payable --8.5M--2.58M--5.9M
-Due to related parties current ------15.44M----
Current accrued expenses --777K--795K--1.13M
Current debt and capital lease obligation --146K--61K----
-Current capital lease obligation --146K--61K----
Other current liabilities --7.68M--430K--56K
Current liabilities --18.04M--19.36M--7.17M
Non current liabilities
Long term debt and capital lease obligation --842K--25.91M--24.98M
-Long term debt ------24.98M--24.98M
-Long term capital lease obligation --842K--925K----
Non current accrued expenses ------961K--214K
Preferred securities outside stock equity --52.84M--2.93M--2.93M
Total non current liabilities --53.68M--29.8M--28.13M
Total liabilities --71.72M--49.16M--35.29M
Shareholders'equity
Share capital --2.97M--0--1K
-common stock --35K--0--1K
-Preferred stock --2.93M--------
Retained earnings ---57.94M---29.32M---7.08M
Paid-in capital --397.35M--339K--17K
Total stockholders'equity --342.37M---28.98M---7.06M
Total equity --342.37M---28.98M---7.06M
Currency Unit USDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data